Esserre was founded with a clear vision: to promote well-being through Mediterranean nutrition. Established in 2013, the company stands out for its scientific and responsible approach to nutraceuticals. Every product is the result of research, technology, and environmental care. Its core values? Quality of life, sustainability, accessible innovation, and social responsibility. Esserre selects high-value ingredients from short supply chains and transforms them into effective nutraceuticals thanks to its in-house laboratory and certified quality systems. The goal is simple yet ambitious: to make science accessible and create tangible solutions that support a healthy lifestyle, through formulations inspired by the principles of the Mediterranean diet and validated by scientific studies.
Europe’s heart under pressure: the urgency of more effective prevention
According to international health bodies such as the World Health Organization and the European Society of Cardiology, cardiovascular diseases are the leading cause of death in Europe, accounting for about 1/3 of all deaths. MedTech Europe, European trade association representing the medical technology industry, highlights some key figures: over 13 million people affected each year and 1.7 million deaths. Cardiovascular deseases strike early, across gender and geography, yet public awareness of cardiovascular health remains low, while the burden on healthcare systems continues to grow. The Council of the European Union has recently called for strengthened prevention efforts, focusing on screening, equitable access to care, and health literacy. In this context, the integration of a healthy lifestyle with targeted nutritional support becomes a strategic approach. This is where nutraceuticals can play a concrete role in managing cardio-metabolic health profiles.
Redulen Cholesterol: a targeted response with Mediterranean roots
To address the growing need for validated formulations, Esserre developed Redulen® Cholesterol: a dietary supplement designed to support cardiovascular health. Its patented international formula combines Brumex® (bergamot extract), Nopalis® (prickly pear extract), phytosterols, and vitamin B1, and is free from monacolin K.Bergamot, cultivated in Calabria, is rich in flavonoids, powerful antioxidants found abundantly in the fruit. Several studies in scientific literature have highlighted its activity in cholesterol regulation. Nopalis®, from the young pads of prickly pear cactus of Sicily, is a source of soluble fibers that modulate nutrient absorption. Phytosterols help maintain normal blood cholesterol levels, while vitamin B1 supports heart function.Esserre clinical studies confirm the properties of the ingredients in the formula in managing normal lipid levels: a reduction in total cholesterol, LDL and TG, along with an increase in HDL. A sustainable and evidence-based solution, Redulen® Cholesterol is now one of the most innovative responses to the growing demand for cardiovascular support, fully aligned with European health priorities.
Via Fliaminia Nuova, 260 00191 Roma (Italy) Ph: +39 06 39736623 info@esserrepharma.it www.esserrepharma.com